Weight-loss drug linked to sleep apnea reduction: Research ...Middle East

The weight-loss drug Zepbound was linked to a reduction in obstructive sleep apnea, according to new research.  Pharmaceutical manufacturer Eli Lilly on Wednesday said injections of its obesity drug tirzepatide — commonly known as Zepbound — “significantly reduced” the number of sleep apnea events during one’s sleep when compared to a placebo. Sleep apnea is a sleep disorder that causes one’s breathing to repeatedly stop and start. The disorder can cause daytime exhaustion, mood changes, headaches and night sweats, according to the Cleveland Clinic. Complications include high blood pressure or heart issues, type 2 diabetes and liver issues.  According to results from two yearlong

Hence then, the article about weight loss drug linked to sleep apnea reduction research was published today ( Wednesday 17/04/2024 - 08:00 PM ) and is available on The Hill ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Weight-loss drug linked to sleep apnea reduction: Research )

Also on site :

• A decade after the ‘Godfather of AI’ said radiologists were obsolete, their salaries are up to $571K and demand is growing fast
• MI vs LSG Dream11 Prediction Today Match, Dream11 Team Today, Fantasy Cricket Tips, Playing XI, Pitch Report, Injury Update- IPL 2026, Match 47
• Quote of the Day: Organizational Psychologist Adam Grant on Rethinking Self-Doubt and Building Confidence